Amlopen® 5mg καψάκια σκληρά clinical trials

Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEBRO Study)

This study compares two common strategies for lowering blood pressure in obese patients. It looks at whether treatments based on eplerenone or irbesartan are better at controlling blood pressure over 24 weeks. The aim is to find effective ways to manage high blood pressure in this group.